Active 0 6 0 6 O
serious 7 14 7 14 O
infections 15 25 15 25 O
not 26 29 26 29 O
controlled 30 40 30 40 O
by 41 43 41 43 O
antibiotics 44 55 44 55 B-treatment

Adequate 0 8 56 64 O
hepatic 9 16 65 72 O
function 17 25 73 81 O
as 26 28 82 84 O
demonstrated 29 41 85 97 O
by 42 44 98 100 O
a 45 46 101 102 O
total 47 52 103 108 B-clinical_variable
bilirubin 53 62 109 118 I-clinical_variable
< 63 64 119 120 O
2.0 65 68 121 124 B-upper_bound
mg 69 71 125 127 I-upper_bound
/ 71 72 127 128 I-upper_bound
dl 72 74 128 130 I-upper_bound
( 75 76 131 132 O
unless 76 82 132 138 O
attributable 83 95 139 151 O
to 96 98 152 154 O
Gilbert 99 106 155 162 B-chronic_disease
's 106 108 162 164 I-chronic_disease
disease 109 116 165 172 I-chronic_disease
) 116 117 172 173 O
and 118 121 174 177 O
an 122 124 178 180 O
alkaline 125 133 181 189 B-clinical_variable
phosphatase 134 145 190 201 I-clinical_variable
, 145 146 201 202 O
AST 147 150 203 206 B-clinical_variable
, 150 151 206 207 O
and 152 155 208 211 O
ALT 156 159 212 215 B-clinical_variable
≤ 160 161 216 217 O
4 162 163 218 219 B-upper_bound
times 164 169 220 225 I-upper_bound
the 170 173 226 229 I-upper_bound
upper 174 179 230 235 I-upper_bound
limit 180 185 236 241 I-upper_bound
of 186 188 242 244 I-upper_bound
normal 189 195 245 251 I-upper_bound
( 196 197 252 253 O
unless 197 203 253 259 O
clinically 204 214 260 270 O
considered 215 225 271 281 O
to 226 228 282 284 O
be 229 231 285 287 O
related 232 239 288 295 O
to 240 242 296 298 O
liver 243 248 299 304 O
involvement 249 260 305 316 O
with 261 265 317 321 O
leukemia 266 274 322 330 B-cancer

Adequate 0 8 331 339 O
renal 9 14 340 345 O
function 15 23 346 354 O
as 24 26 355 357 O
demonstrated 27 39 358 370 O
by 40 42 371 373 O
a 43 44 374 375 O
serum 45 50 376 381 B-clinical_variable
creatinine 51 61 382 392 I-clinical_variable
≤ 62 63 393 394 O
2.0 64 67 395 398 B-upper_bound
mg 68 70 399 401 I-upper_bound
/ 70 71 401 402 I-upper_bound
dl 71 73 402 404 I-upper_bound
or 74 76 405 407 O
a 77 78 408 409 O
creatinine 79 89 410 420 B-clinical_variable
clearance 90 99 421 430 I-clinical_variable
of 100 102 431 433 O
> 103 104 434 435 O
60 105 107 436 438 B-lower_bound
ml 108 110 439 441 I-lower_bound
/ 110 111 441 442 I-lower_bound
min 111 114 442 445 I-lower_bound

Age 0 3 446 449 B-age
18 4 6 450 452 B-lower_bound
- 7 8 453 454 O
60 9 11 455 457 B-upper_bound
years 12 17 458 463 I-upper_bound

Clinically 0 10 464 474 O
significant 11 22 475 486 O
cardiac 23 30 487 494 B-chronic_disease
disease 31 38 495 502 I-chronic_disease
( 39 40 503 504 O
NY 40 42 504 506 O
Heart 43 48 507 512 O
Association 49 60 513 524 O
Class 61 66 525 530 O
III 67 70 531 534 O
or 71 73 535 537 O
IV 74 76 538 540 O
) 76 77 540 541 O
, 77 78 541 542 O
including 79 88 543 552 O
chronic 89 96 553 560 B-chronic_disease
arrhythmias 97 108 561 572 I-chronic_disease
, 108 109 572 573 O
or 110 112 574 576 O
pulmonary 113 122 577 586 B-chronic_disease
disease 123 130 587 594 I-chronic_disease

Concurrent 0 10 595 605 O
active 11 17 606 612 O
malignancy 18 28 613 623 B-cancer
requiring 29 38 624 633 O
immediate 39 48 634 643 O
therapy 49 56 644 651 B-treatment

ECOG 0 4 652 656 B-clinical_variable
performance 5 16 657 668 I-clinical_variable
status 17 23 669 675 I-clinical_variable
of 24 26 676 678 O
0 27 28 679 680 B-lower_bound
- 28 29 680 681 O
2 29 30 681 682 B-upper_bound

For 0 3 683 686 O
patients 4 12 687 695 O
with 13 17 696 700 O
CNS 18 21 701 704 B-chronic_disease
disease 22 29 705 712 I-chronic_disease
, 29 30 712 713 O
dexamethasone 31 44 714 727 B-treatment
may 45 48 728 731 O
be 49 51 732 734 O
temporarily 52 63 735 746 O
administered 64 76 747 759 O
instead 77 84 760 767 O
of 85 87 768 770 O
prednisone 88 98 771 781 B-treatment
to 99 101 782 784 O
reduce 102 108 785 791 O
CNS 109 112 792 795 O
pressure 113 121 796 804 O
, 121 122 804 805 O
at 123 125 806 808 O
the 126 129 809 812 O
discretion 130 140 813 823 O
of 141 143 824 826 O
the 144 147 827 830 O
treating 148 156 831 839 O
physician 157 166 840 849 O
and 167 170 850 853 O
after 171 176 854 859 O
discussion 177 187 860 870 O
with 188 192 871 875 O
the 193 196 876 879 O
MSK 197 200 880 883 O
PI 201 203 884 886 O

Known 0 5 887 892 O
HIV 6 9 893 896 B-chronic_disease
positive 10 18 897 905 O
status 19 25 906 912 O

Leukemia 0 8 913 921 B-cancer
cell 9 13 922 926 O
samples 14 21 927 934 O
will 22 26 935 939 O
be 27 29 940 942 O
obtained 30 38 943 951 O
from 39 43 952 956 O
all 44 47 957 960 O
patients 48 56 961 969 O
enrolled 57 65 970 978 O
before 66 72 979 985 O
starting 73 81 986 994 O
protocol 82 90 995 1003 O
treatment 91 100 1004 1013 O
and 101 104 1014 1017 O
submitted 105 114 1018 1027 O
for 115 118 1028 1031 O
Philadelphia 119 131 1032 1044 O
chromosome 132 142 1045 1055 O
testing 143 150 1056 1063 O
by 151 153 1064 1066 O
either 154 160 1067 1073 O
karyotyping 161 172 1074 1085 O
, 172 173 1085 1086 O
or 174 176 1087 1089 O
for 177 180 1090 1093 O
bcr 181 184 1094 1097 O
/ 184 185 1097 1098 O
abl1 185 189 1098 1102 O
translocation 190 203 1103 1116 O
by 204 206 1117 1119 O
FISH 207 211 1120 1124 O
or 212 214 1125 1127 O
by 215 217 1128 1130 O
PCR 218 221 1131 1134 O
for 222 225 1135 1138 O
bcr 226 229 1139 1142 O
/ 229 230 1142 1143 O
abl1 230 234 1143 1147 O

Lymphoid 0 8 1148 1156 B-cancer
blastic 9 16 1157 1164 I-cancer
crisis 17 23 1165 1171 O
of 24 26 1172 1174 O
chronic 27 34 1175 1182 B-cancer
myelogenous 35 46 1183 1194 I-cancer
leukemia 47 55 1195 1203 I-cancer

Mature 0 6 1204 1210 B-cancer
B 7 8 1211 1212 I-cancer
- 8 9 1212 1213 I-cancer
cell 9 13 1213 1217 I-cancer
( 14 15 1218 1219 I-cancer
Burkitt 15 22 1219 1226 I-cancer
's 22 24 1226 1228 I-cancer
) 24 25 1228 1229 I-cancer
ALL 26 29 1230 1233 I-cancer

Men 0 3 1234 1237 B-gender
and 4 7 1238 1241 I-gender
women 8 13 1242 1247 I-gender
of 14 16 1248 1250 O
childbearing 17 29 1251 1263 O
potential 30 39 1264 1273 O
must 40 44 1274 1278 O
be 45 47 1279 1281 O
willing 48 55 1282 1289 B-contraception_consent
to 56 58 1290 1292 I-contraception_consent
practice 59 67 1293 1301 I-contraception_consent
an 68 70 1302 1304 I-contraception_consent
effective 71 80 1305 1314 I-contraception_consent
method 81 87 1315 1321 I-contraception_consent
of 88 90 1322 1324 I-contraception_consent
birth 91 96 1325 1330 I-contraception_consent
control 97 104 1331 1338 I-contraception_consent
during 105 111 1339 1345 O
treatment 112 121 1346 1355 B-treatment
and 122 125 1356 1359 O
at 126 128 1360 1362 O
least 129 134 1363 1368 O
4 135 136 1369 1370 B-lower_bound
months 137 143 1371 1377 I-lower_bound
after 144 149 1378 1383 O
treatment 150 159 1384 1393 O
is 160 162 1394 1396 O
finished 163 171 1397 1405 O

Negative 0 8 1406 1414 B-pregnancy
serum 9 14 1415 1420 I-pregnancy
pregnancy 15 24 1421 1430 I-pregnancy
test 25 29 1431 1435 O
in 30 32 1436 1438 O
women 33 38 1439 1444 B-gender
of 39 41 1445 1447 O
childbearing 42 54 1448 1460 O
potential 55 64 1461 1470 O

Normal 0 6 1471 1477 O
cardiac 7 14 1478 1485 O
function 15 23 1486 1494 O
as 24 26 1495 1497 O
demonstrated 27 39 1498 1510 O
by 40 42 1511 1513 O
a 43 44 1514 1515 O
left 45 49 1516 1520 B-clinical_variable
ventricular 50 61 1521 1532 I-clinical_variable
ejection 62 70 1533 1541 I-clinical_variable
fraction 71 79 1542 1550 I-clinical_variable
≥ 80 81 1551 1552 O
50 82 84 1553 1555 B-lower_bound
% 84 85 1555 1556 I-lower_bound
on 86 88 1557 1559 O
echocardiogram 89 103 1560 1574 O
or 104 106 1575 1577 O
MUGA 107 111 1578 1582 O
scan 112 116 1583 1587 O

Patients 0 8 1588 1596 O
known 9 14 1597 1602 O
to 15 17 1603 1605 O
have 18 22 1606 1610 O
Philadelphia 23 35 1611 1623 B-cancer
( 36 37 1624 1625 I-cancer
Ph)+ 37 41 1625 1629 I-cancer
ALL 42 45 1630 1633 I-cancer
are 46 49 1634 1637 O
not 50 53 1638 1641 O
eligible 54 62 1642 1650 O

Patients 0 8 1651 1659 O
who 9 12 1660 1663 O
are 13 16 1664 1667 O
later 17 22 1668 1673 O
found 23 28 1674 1679 O
to 29 31 1680 1682 O
have 32 36 1683 1687 O
Ph+ 37 40 1688 1691 B-cancer
ALL 41 44 1692 1695 I-cancer
should 45 51 1696 1702 O
have 52 56 1703 1707 O
treatment 57 66 1708 1717 O
on 67 69 1718 1720 O
this 70 74 1721 1725 O
trial 75 80 1726 1731 O
discontinued 81 93 1732 1744 O
and 94 97 1745 1748 O
will 98 102 1749 1753 O
not 103 106 1754 1757 O
be 107 109 1758 1760 O
considered 110 120 1761 1771 O
in 121 123 1772 1774 O
the 124 127 1775 1778 O
evaluation 128 138 1779 1789 O

Patients 0 8 1790 1798 O
who 9 12 1799 1802 O
have 13 17 1803 1807 O
untreated 18 27 1808 1817 O
B 28 29 1818 1819 B-cancer
- 29 30 1819 1820 I-cancer
cell 30 34 1820 1824 I-cancer
or 35 37 1825 1827 O
T 38 39 1828 1829 B-cancer
- 39 40 1829 1830 I-cancer
cell 40 44 1830 1834 I-cancer
ALL 45 48 1835 1838 I-cancer
confirmed 49 58 1839 1848 O
by 59 61 1849 1851 O
conventional 62 74 1852 1864 B-treatment
flow 75 79 1865 1869 I-treatment
cytometry 80 89 1870 1879 I-treatment
or 90 92 1880 1882 O
immunohistochemical 93 112 1883 1902 B-treatment
stain 113 118 1903 1908 I-treatment
, 118 119 1908 1909 O
but 120 123 1910 1913 O
Ph 124 126 1914 1916 O
status 127 133 1917 1923 O
is 134 136 1924 1926 O
unknown 137 144 1927 1934 O
, 144 145 1934 1935 O
may 146 149 1936 1939 O
also 150 154 1940 1944 O
enroll 155 161 1945 1951 O

Patients 0 8 1952 1960 O
with 9 13 1961 1965 O
T 14 15 1966 1967 B-cancer
- 15 16 1967 1968 I-cancer
cell 16 20 1968 1972 I-cancer
or 21 23 1973 1975 I-cancer
B 24 25 1976 1977 I-cancer
cell 26 30 1978 1982 I-cancer
lymphoblastic 31 44 1983 1996 I-cancer
lymphoma 45 53 1997 2005 I-cancer
confirmed 54 63 2006 2015 O
by 64 66 2016 2018 O
conventional 67 79 2019 2031 O
immature 80 88 2032 2040 B-treatment
T- 89 91 2041 2043 I-treatment
or 92 94 2044 2046 O
pre 95 98 2047 2050 B-treatment
B 99 100 2051 2052 I-treatment
cell 101 105 2053 2057 I-treatment
markers 106 113 2058 2065 I-treatment
even 114 118 2066 2070 O
if 119 121 2071 2073 O
the 122 125 2074 2077 O
bone 126 130 2078 2082 O
marrow 131 137 2083 2089 O
is 138 140 2090 2092 O
not 141 144 2093 2096 O
involved 145 153 2097 2105 O
are 154 157 2106 2109 O
also 158 162 2110 2114 O
eligible 163 171 2115 2123 O

Patients 0 8 2124 2132 O
with 9 13 2133 2137 O
central 14 21 2138 2145 B-chronic_disease
nervous 22 29 2146 2153 I-chronic_disease
system 30 36 2154 2160 I-chronic_disease
involvement 37 48 2161 2172 I-chronic_disease
by 49 51 2173 2175 O
ALL 52 55 2176 2179 B-cancer
are 56 59 2180 2183 O
eligible 60 68 2184 2192 O
and 69 72 2193 2196 O
may 73 76 2197 2200 O
receive 77 84 2201 2208 O
concomitant 85 96 2209 2220 B-treatment
treatment 97 106 2221 2230 I-treatment
with 107 111 2231 2235 O
radiation 112 121 2236 2245 B-treatment
therapy 122 129 2246 2253 I-treatment
and/or 130 136 2254 2260 O
intrathecal 137 148 2261 2272 B-treatment
chemotherapy 149 161 2273 2285 I-treatment
in 162 164 2286 2288 O
accordance 165 175 2289 2299 O
with 176 180 2300 2304 O
standard 181 189 2305 2313 O
medical 190 197 2314 2321 O
practice 198 206 2322 2330 O

Pregnant 0 8 2331 2339 B-pregnancy
women 9 14 2340 2345 B-gender
or 15 17 2346 2348 I-gender
women 18 23 2349 2354 I-gender
who 24 27 2355 2358 O
are 28 31 2359 2362 O
breast 32 38 2363 2369 O
- 38 39 2369 2370 O
feeding 39 46 2370 2377 O

Previous 0 8 2378 2386 O
treatment 9 18 2387 2396 O
for 19 22 2397 2400 O
ALL 23 26 2401 2404 O
, 26 27 2404 2405 O
except 28 34 2406 2412 O
for 35 38 2413 2416 O
prior 39 44 2417 2422 O
steroids 45 53 2423 2431 B-treatment
and/or 54 60 2432 2438 O
hydroxyurea 61 72 2439 2450 B-treatment

Previously 0 10 2451 2461 O
untreated 11 20 2462 2471 O
Ph 21 23 2472 2474 B-cancer
negative 24 32 2475 2483 I-cancer
precursor 33 42 2484 2493 I-cancer
B 43 44 2494 2495 I-cancer
- 44 45 2495 2496 I-cancer
cell 45 49 2496 2500 I-cancer
or 50 52 2501 2503 O
T 53 54 2504 2505 B-cancer
- 54 55 2505 2506 I-cancer
cell 55 59 2506 2510 I-cancer
ALL 60 63 2511 2514 I-cancer
confirmed 64 73 2515 2524 O
by 74 76 2525 2527 O
conventional 77 89 2528 2540 O
flow 90 94 2541 2545 O
cytometry 95 104 2546 2555 O
or 105 107 2556 2558 O
immunohistochemical 108 127 2559 2578 O
stain 128 133 2579 2584 O

